Bridges, John F.P.; Onukwugha, Eberechukwu; Mullins, C. … - In: PharmacoEconomics 28 (2010) 3, pp. 175-184
The application of cost-effectiveness analysis in healthcare has become commonplace in the US, but the validity of this approach is in jeopardy unless the proverbial $US50 000 per QALY benchmark for determining value for money is updated for the 21st century. While the initial aim of this...
